ELAN Trial: Early Initiation of DOACs Reduces Event Risk after Stroke Event
Presented at the European Stroke Conference, results of the ELAN trial offer evidence in support of early initiation, as opposed to later initiation, strategies for anticoagulation following acute ischemic stroke in patients with atrial fibrillation.
Source: hcplive.com